Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 2.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved audited standalone and consolidated financial results for Q4 and the full financial year ended 31st March, 2025, along with the auditor's report and cash flow statements. The board appointed M/s. Maganlal & Ajay Mehta, Chartered Accountants (FRN: 105730W), as the Internal Auditor for FY 2025-26. The board recommended a 5% dividend (₹0.05 per share) on equity shares of face value ₹1 each, subject to shareholder approval. Additionally, a 2% dividend was recommended on Redeemable Non-convertible Non-cumulative Non-participating Preference Shares of face value ₹1 each. The meeting ran from 12:00 noon to 2:00 PM.
The FY25 results have been formally approved and the modest equity dividend of ₹0.05 per share signals a small payout to shareholders, pending AGM approval. The annual internal auditor appointment is routine and unlikely to affect the stock price materially.